Back to Companies
Monopar Therapeutics
MNPRNasdaqCIK: 0001645469
Over the 36 most recent insider filings, Monopar Therapeutics (MNPR) has seen activity from 13 distinct insiders — 1 buying and 7 selling. The activity is heavily weighted toward selling: $104.9K bought versus $38.7M sold, net sales of $38.6M. Tactic Pharma LLC (Chief Executive Officer, Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $35.0M by Tactic Pharma LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$47.1M
Purchases
$104.9K
Sales
$38.7M
Unique Insiders
13
Recent Insider Trades
36 loaded
| Aug 28 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $455.6K |
| Aug 27 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $455.6K |
| Aug 27 | MNPR Monopar Therapeutics | RIOUX PATRICE | Insider | Sell | $111 |
| Aug 28 | MNPR Monopar Therapeutics | Anderson Raymond | Director | Sell | $351.8K |
| Aug 27 | MNPR Monopar Therapeutics | Anderson Raymond | Director | Sell | $351.2K |
| Jul 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $378.1K |
| Jul 2 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Exercise | $46.9K |
| Jul 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $213.8K |
| Jun 30 | MNPR Monopar Therapeutics | Sweeny Nicole | Director | Award | $112.6K |
| Jun 30 | MNPR Monopar Therapeutics | Sweeny Nicole | Director | Other | $0 |
| Apr 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $108.0K |
| Apr 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $86.1K |
| Mar 4 | MNPR Monopar Therapeutics | Rodriguez Susan | CCSO | Other | $0 |
| Mar 4 | MNPR Monopar Therapeutics | Rodriguez Susan | CCSO | Award | $2.6M |
| Jan 5 | MNPR Monopar Therapeutics | RIOUX PATRICE | Insider | Award | $130.6K |
| Jan 5 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $123.4K |
| Jan 5 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $167.0K |
| Dec 29 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Buy | $104.9K |
| Dec 19 | MNPR Monopar Therapeutics | KLAUSNER ARTHUR J | Director | Sell | $343.9K |
| Dec 17 | MNPR Monopar Therapeutics | Hendricks Diane | 10% Owner | Other | $0 |
| Dec 17 | MNPR Monopar Therapeutics | KLAUSNER ARTHUR J | Director | Other | $0 |
| Dec 8 | MNPR Monopar Therapeutics | Talukdar Lavina | Director | Award | $222.0K |
| Dec 8 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Award | $1.3M |
| Dec 8 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Award | $222.0K |
| Dec 8 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Award | $681.1K |
| Dec 8 | MNPR Monopar Therapeutics | Anderson Raymond | Director | Award | $222.0K |
| Dec 8 | MNPR Monopar Therapeutics | KLAUSNER ARTHUR J | Director | Award | $222.0K |
| Dec 8 | MNPR Monopar Therapeutics | STARR CHRISTOPHER M | Director | Award | $222.0K |
| Dec 8 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Award | $541.8K |
| Oct 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $216.1K |
| Oct 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $154.8K |
| Sep 26 | MNPR Monopar Therapeutics | Tactic Pharma LLC | Chief Executive Officer, Director, 10% Owner | Sell | $35.0M |
| Jul 16 | MNPR Monopar Therapeutics | Tsuchimoto Kim R | Director | Sell | $356.2K |
| Jul 16 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Sell | $672.0K |
| Jul 16 | MNPR Monopar Therapeutics | STARR CHRISTOPHER M | Director | Sell | $672.0K |
| Jan 30 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Other | $0 |
36 filings